Lupus
Updated: 01/25/2006

References

Adachi JD, Bensen WG, et al. Vitamin D and calcium in the prevention of corticosteroid-induced osteoporosis: a 3-year followup. J Rheumatol . 1996 Jun;23(6):995-1000.

Afeltra A, Vadacca M, et al. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors. Arthritis Rheum . 2005 Jun 15;53(3):452-9.

Agisheva KN, Salikhov IG. Lipid peroxidation and state of antioxidant system in patients with systemic lupus erythematosus. Klin Med (Mosk) . 1990 Apr;68(4):99-102.

Ayres S Jr, Mihan R. Is vitamin E involved in the autoimmune mechanism? Cutis . 1978 Mar;21(3):321-5.

Bae SC , Kim SJ, et al. Impaired antioxidant status and decreased dietary intake of antioxidants in patients with systemic lupus erythematosus. Rheumatol Int . 2002 Nov;22(6):238-43.

Becker A, Fischer R, et al. Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Z Rheumatol . 2001 Oct;60(5):352-8.

Bhattacharya A, Lawrence RA, et al. Effect of dietary n-3 and n-6 oils with and without food restriction on activity of antioxidant enzymes and lipid peroxidation in livers of cyclophosphamide-treated autoimmune-prone NZB/W female mice. J Am Coll Nutr . 2003 Oct;22(5):388-99.

Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Rev . 2001 May;2(2):73-86.

Brooks WH. Systemic lupus erythematosus and related autoimmune diseases are antigen-driven, epigenetic diseases. Med Hypotheses . 2002 Dec;59(6):736-41.

Brown AC. Lupus erythematosus and nutrition: a review of the literature. J Ren Nutr . 2000 Oct;10(4):170-83.

Bruce IN. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology ( Oxford ) 2005 Dec;44(12)1492-1502.

Bultink IE, Lems WH, et al. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum. 2005 Jul;52(7):2044-50.

Buyon JP, Petri MA, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med . 2005 Jun 21;142(pt 1):953-62.

Chang DM, Chu SJ, et al. Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus. Ann Rheum Dis . 2004 Dec;63(12):1623-6.

Chen CC, Parker CR Jr. Adrenal androgens and the immune system. Semin Reprod Med . 2004 Nov;22(4):369-77.

Clark WF, Parbtani A, et al. Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus. Kidney Int . 1989 Oct;36(4):653-60.

Clark WF, Parbtani A. Omega-3 fatty acid supplementation in clinical and experimental lupus nephritis. Am J Kidney Dis . 1994 May;23(5):644-7.

Cutolo M, Sulli A, et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus . 2004;13(9):635-8.

Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J . 2001 Dec;15(14):2579-85.

DiMunno O, Mazzantini M, et al. Risk factors for osteoporosis in female patients with systemic lupus erythematosus. Lupus . 2004;13(9):724-30.

Donadio JV Jr. Omega-3 polyunsaturated fatty acids: a potential new treatment of immune renal disease. Mayo Clin Proc . 1991 Oct;66(10):1018-28.

Duffy EM, Meenagh GK, et al. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus. J Rheumatol . 2004 Aug;31(8):1551-6.

Fernandes G, Chandrasekar B, et al. Modulation of antioxidant enzymes and programmed cell death by n-3 fatty acids. Lipids . 1996 Mar;31(suppl):S91-S96.

Folomeev M, Dougados M, et al. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus . 1992 May;1(3):191-5.

Formiga F, Moga I, et al. The association of dehydroepiandrosterone sulphate levels with bone mineral density in systemic lupus erythematosus. Clin Exp Rheumatol . 1997 Jul-Aug;15:387-92.

Franchimont N, Canalis E. Management of glucocorticoid-induced osteoporosis in premenopausal women with autoimmune disease. Autoimmun Rev . 2003 Jun;2(4):224-8.

Godfrey DG, Stimson WH, et al. Effects of dietary supplementation on autoimmunity in the MRL/lpr mouse: a preliminary investigation. Ann Rheum Dis . 1986 Dec;45(12):1019-24.

Grimaldi CM, Cleary J, et al. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest . 2002 Jun;109(12):1625-33.

Huang CM, Wu MC, et al. Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus . 2002;11(1):31-4.

Huisman AM, White KP, et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol . 2001 Nov;28(11):2535-9.

Januchowski R, Prokop J, et al. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J Appl Genet . 2004;45(2):237-48.

Juhlin L, Edqvist LE, et al. Blood glutathione-peroxidase levels in skin diseases: effect of selenium and vitamin E treatment. Acta Derm Venereol . 1982;62(3):211-4.

Kanda N, Tsuchida T, et al. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum . 1999 Feb;42(2):328-37.

Kasper DL, Braunwald E, et al, eds. Harrison 's Principles of Internal Medicine. 16th ed. New York , NY : McGraw-Hill; 2004

Linker-Israeli M, Elstner E, et al. Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol . 2001 Apr;99(1):82-93.

May E, Asadullah K, et al. Immunoregulation through 1,25-dihydroxyvitamin D3 and its analogs. Curr Drug Targets Inflamm Allergy. 2004 Dec;3(4):377-93.

Muthukumar A, Sun D, et al. Age-associated alterations in costimulatory and adhesion molecule expression in lupus-prone mice are attenuated by food restriction with n-6 and n-3 fatty acids. J Clin Immunol, 2004 Sep;24(5):471-80.

Nakamura S, Kumasaka R, et al. Effects of eicosapentaenoic acids on oxidative stress and plasma fatty acid composition in patients with lupus nephritis. In Vivo . 2005 Sep-Oct;19(5):879-82.

Ozaki Y, Nomura S, et al. Vitamin-D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus. Nephron . 2000 May;85(1):86-91.

Parke DV, Sapota A. Chemical toxicity and reactive oxygen species. Int J Occup Med Environ Health . 1996;9(4):331-40.

Patavino T, Brady DM. Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus. Altern Med Rev . 2001 Oct;6(5):460-71.

Perez de Lema G, Lucio-Cazana FJ, et al. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. Kidney Int. 2004 Sep;66(3):1018-28.

Petri M. Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy. Lupus . 2001;10(3):222-6.

Sen D, Keen RW. Osteoporosis in systemic lupus erythematosus: prevention and treatment. Lupus . 2001;10(3):227-32.

Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002 Dec;21(6):495-505.

Sprietsma JE. Modern diets and diseases: NO-zinc balance. Under Th1, zinc and nitrogen monoxide (NO) collectively protect against viruses, AIDS, autoimmunity, diabetes, allergies, asthma, infectious diseases, atherosclerosis and cancer. Med Hypotheses . 1999 Jul;53(1):6-16.

Tam LS, Li EK, et al. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double-blind, placebo-controlled pilot study. J Rheumatol . 2005 Feb;32(2):275-82.

van Vollenhoven RF. Dehydroepiandrosterone in systemic lupus erythematosus. Rheum Dis Clin North Am . 2000 May;26(2):349-62.

van Vollenhoven RF, Morabito LM, et al. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. J Rheumatol . 1998 Feb;25(2):285-9.

van Vollenhoven RF, Park JL, et al. A double-blind, placebo-controlled, clinical trial of dehydroepiandresterone in severe systemic lupus erythematosus. Lupus . 1999;8(3):181-7.

Wake DJ, Walker BR. 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Mol Cell Endocrinol . 2004 Feb 27;215(1-2):45-54.

Weimann BJ, Hermann D. Inhibition of autoimmune deterioration in MRL/lpr mice by vitamin E. Int J Vitam Nutr Res . 1999 Jul;69(4):255-61.

Zhao JH, Sun SJ, et al. A soy diet accelerates renal damage in autoimmune MRL/Mp-Ipr/lpr mice. Int Immunopharmacol . 2005 Oct;5(11):1601-10.